Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Related Citations for PubMed (Select 23145797)

1.

Ether à go-go 1 silencing in combination with TRAIL overexpression has synergistic antitumor effects on osteosarcoma.

Wu J, Zeng T, Wu X, Gao Q, Zhai W, Ding Z.

Cancer Biother Radiopharm. 2013 Feb;28(1):65-70. doi: 10.1089/cbr.2012.1283. Epub 2012 Nov 12.

PMID:
23145797
2.

Silencing of Ether à go-go 1 by shRNA inhibits osteosarcoma growth and cell cycle progression.

Wu J, Zhong D, Fu X, Liu Q, Kang L, Ding Z.

Int J Mol Sci. 2014 Apr 1;15(4):5570-81. doi: 10.3390/ijms15045570.

3.

MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression.

Wu X, Zhong D, Gao Q, Zhai W, Ding Z, Wu J.

Int J Med Sci. 2013;10(6):676-82. doi: 10.7150/ijms.5528. Epub 2013 Apr 3.

4.

Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC.

Pan Q, Liu B, Liu J, Cai R, Liu X, Qian C.

Acta Oncol. 2008;47(1):135-44.

PMID:
17934893
5.

Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.

Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Gschwend JE, Simmet T, Debatin KM, Fulda S.

Cancer Res. 2008 Oct 1;68(19):7956-65. doi: 10.1158/0008-5472.CAN-08-1296.

7.

The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.

Zhao L, Dong A, Gu J, Liu Z, Zhang Y, Zhang W, Wang Y, He L, Qian C, Qian Q, Liu X.

Cancer Gene Ther. 2006 Nov;13(11):1011-22. Epub 2006 Jun 23.

PMID:
16799468
8.

Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.

Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL.

Clin Cancer Res. 2008 May 15;14(10):3168-76. doi: 10.1158/1078-0432.CCR-07-4362.

9.

Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation.

Moon MH, Jeong JK, Seo JS, Seol JW, Lee YJ, Xue M, Jackson CJ, Park SY.

Exp Mol Med. 2011 Mar 31;43(3):138-45. doi: 10.3858/emm.2011.43.3.016.

11.

Restoration of XAF1 expression induces apoptosis and inhibits tumor growth in gastric cancer.

Tu SP, Liston P, Cui JT, Lin MC, Jiang XH, Yang Y, Gu Q, Jiang SH, Lum CT, Kung HF, Korneluk RG, Wong BC.

Int J Cancer. 2009 Aug 1;125(3):688-97. doi: 10.1002/ijc.24282.

PMID:
19358264
12.

Efficient melanoma cell killing and reduced melanoma growth in mice by a selective replicating adenovirus armed with tumor necrosis factor-related apoptosis-inducing ligand.

Fecker LF, Rückert S, Kurbanov BM, Schmude M, Stockfleth E, Fechner H, Eberle J.

Hum Gene Ther. 2011 Apr;22(4):405-17. doi: 10.1089/hum.2010.108. Epub 2011 Feb 16.

PMID:
20977303
13.

Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.

Khanbolooki S, Nawrocki ST, Arumugam T, Andtbacka R, Pino MS, Kurzrock R, Logsdon CD, Abbruzzese JL, McConkey DJ.

Mol Cancer Ther. 2006 Sep;5(9):2251-60.

14.

Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.

Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P, Xie R, Zhou L, Zhu J.

Neurosurgery. 2009 Sep;65(3):610-24; discussion 624. doi: 10.1227/01.NEU.0000350227.61132.A7.

PMID:
19687708
15.

An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.

Pei Z, Chu L, Zou W, Zhang Z, Qiu S, Qi R, Gu J, Qian C, Liu X.

Hepatology. 2004 May;39(5):1371-81.

PMID:
15122766
17.

Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells.

Kim DR, Park MY, Lee CS, Shim SH, Yoon HI, Lee JH, Sung MW, Kim YS, Lee CT.

Cancer Gene Ther. 2011 Jul;18(7):467-77. doi: 10.1038/cgt.2011.11. Epub 2011 Apr 1.

PMID:
21455254
18.

Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma.

Lamoureux F, Picarda G, Garrigue-Antar L, Baud'huin M, Trichet V, Vidal A, Miot-Noirault E, Pitard B, Heymann D, Rédini F.

Cancer Res. 2009 Jan 15;69(2):526-36. doi: 10.1158/0008-5472.CAN-08-2648.

19.

Adenovirus-mediated TRAIL expression and downregulation of Bcl-2 expression suppresses non-small cell lung cancer growth in vitro and in vivo.

Zhang H, Sui A, Wang Z, Liu S, Yao R.

Int J Mol Med. 2012 Aug;30(2):358-64. doi: 10.3892/ijmm.2012.998. Epub 2012 May 14.

PMID:
22614533
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk